Deborah Margaret Brown Insider Profile
11 Followers
Deborah Margaret Brown, Director at Oncolytics Biotech, holds 109.85K shares in Oncolytics Biotech (Ticker: ONCY). Most recently, Deborah Margaret Brown Bought 25,000 shares of Oncolytics Biotech on Feb 13, 2026 for an estimated value of $21.00K.
Deborah Margaret Brown has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Deborah Margaret Brown's holdings
Insider Roles
Director
Roles that Deborah Margaret Brown holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Deborah Margaret Brown
Deborah Margaret Brown's Trading History
List of latest transactions for each holding click on a transaction to see Deborah Margaret Brown's performance on stock
You May Also Like
Deborah Margaret Brown insider profile FAQ
What is the percentage of profitable transactions made by Deborah Margaret Brown?
The percentage of profitable transactions made by Deborah Margaret Brown is ―.
What is the average return per transaction made by Deborah Margaret Brown?
The average return per transaction made by Deborah Margaret Brown is ―.
What stocks does Deborah Margaret Brown hold?
Deborah Margaret Brown holds: ONCY stocks.
What was Deborah Margaret Brown’s latest transaction?
Deborah Margaret Brown latest transaction was an Informative Buy of $21.00K.
What was Deborah Margaret Brown's most profitable transaction?
Deborah Margaret Brown’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Deborah Margaret Brown's role in Oncolytics Biotech?
Deborah Margaret Brown's role in Oncolytics Biotech is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.